INVA

Q: What is the price of Innoviva (INVA) today?

The current price of Innoviva (INVA) is $ 23.57, representing a 29.22% gain over the past year. The stock began the year trading around $ 19.99 and is currently priced at $ 23.57. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not pay dividends over the past year.

Q: Is Innoviva (INVA) a good investment?

Innoviva (INVA) is currently trading at $ 23.57 with a P/E ratio of 6.52%. This represents a 1,593% premium compared to its historical average P/E. Over the past year, the stock has gained 29.22 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 29.22%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Innoviva Inc.

Price

$ 23.57

return (12m)

29.22%

p/e

6.52

p/bv

1.51

DIVIDEND YIELD

0.00%

INVA price

INVA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment INVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.02%

3 months

20.75%

1 year

29.22%

2 years

54.46%

5 years

103.36%

10 years

91.00%

Fundamentals INVA

review the fundamentals of Innoviva shares

P/E

6.52

Sector: -4.04 Industry: -4.04

P/S (PSR)

4.30

Sector: -3.86 Industry: -3.86

P/BV

1.51

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

16.58%

Sector: -61.23% Industry: -61.23%

ROE

23.12%

Sector: -60.44% Industry: -60.44%

ROIC

13.81%

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

65.93%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

84.35%

Sector: 37.91% Industry: 37.91%

OPERATING MARGIN

39.81%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

4.78

Sector: -3.92 Industry: -3.92

EV/EBIT

5.15

Sector: -4.14 Industry: -4.14

PRICE-TO-ASSETS

1.08

Sector: 1.41 Industry: 1.41

BVPS

15.64

Sector: 1.88 Industry: 1.88

EPS

3.62

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.72

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.28

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.97%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.40%

Sector: - Industry: -

FAIR VALUE OF Innoviva ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 23.57

Fair Value

$ 0.00

Upside/Downside Return potential.

51.43%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals INVA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.05	6.75	25.92%	2.29%	$ 548.05 B	21.83%
PFE	19.76	1.65	8.35%	6.37%	$ 153.52 B	12.42%
ABBV	83.09	0.00	0.00%	3.35%	$ 351.12 B	6.91%
NVO	11.67	6.01	51.50%	4.53%	$ 182.84 B	33.05%
MRK	15.22	0.00	0.00%	2.97%	$ 277.74 B	28.08%
AZN	28.78	6.04	20.99%	1.69%	$ 294.30 B	17.41%
GILD	19.03	7.16	37.62%	2.45%	$ 161.96 B	28.90%
BMY	16.77	-3.48	-20.72%	4.28%	$ 118.31 B	14.64%
ZTS	19.15	15.37	80.25%	1.74%	$ 51.19 B	28.23%
REGN	17.18	2.48	14.41%	0.48%	$ 77.41 B	31.41%
HALO	24.34	158.01	649.21%	0.00%	$ 7.71 B	22.69%
AMGN	24.08	21.45	89.06%	2.80%	$ 185.71 B	20.98%
MCK	23.47	-1,028.86	-4,383.84%	0.38%	$ 101.86 B	1.09%
VRTX	27.65	5.86	21.18%	0.00%	$ 109.29 B	32.94%
HRMY	11.06	2.02	18.24%	0.00%	$ 1.76 B	18.27%
CAH	28.38	-17.47	-61.56%	1.02%	$ 47.16 B	0.68%
ADMA	18.24	5.61	30.78%	0.00%	$ 2.68 B	28.80%
BIIB	20.96	1.48	7.08%	0.00%	$ 27.10 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

INVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/10/2015	09/30/2015	0,25000000
Dividends	06/12/2015	06/30/2015	0,25000000
Dividends	03/12/2015	03/31/2015	0,25000000
Dividends	11/25/2014	12/23/2014	0,25000000
Dividends	08/28/2014	09/18/2014	0,25000000

ABOUT Innoviva

Innoviva Inc.

Average Investor10 user rating

4.0 (1 people)

United States

30 years

Founded: 1996

2004

Time since IPO - 22 years

5

Employees

Innoviva Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.77 Billion, with shareholders equity totaling $1.17 Billion.

The company employs approximately 5 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Innoviva Inc. reported $411.32 Millions in revenue, generating net income of $271.17 Millions.

Key financial metrics include a P/E ratio of 6.52, a price-to-book (P/B) ratio of 1.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INVA.

Market cap

$ 1.77 Billion

Net worth

$ 1.17 Billion

$ 1,172,840,000.00

Assets

$ 1.64 Billion

$ 1,635,160,000.00

Total Shares Outstanding

75.00 Millions

75,000,000

Average Daily Trading Volume

$ 741.06 Thousand

$ 741,060.74

Sector

Health Care

Industry

Biotechnology

INVA

INVA revenue and profits

Financial Results INVA

DRAG THE FRAME TO SEE MORE DATA

INVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 828.11 19,74% (12M)

P/E

23.47

0.38%

ROE

-4,383.84%

P/BV

-1,028.86

CAH - Cardinal Health

$ 199.85 46,92% (12M)

P/E

28.38

1.02%

ROE

-61.56%

P/BV

-17.47

JNJ - Johnson & Johnson

$ 227.50 52,17% (12M)

P/E

26.05

2.29%

ROE

25.92%

P/BV

6.75

PFE - Pfizer

$ 27.00 28,40% (12M)

P/E

19.76

6.37%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 198.71 11,21% (12M)

P/E

83.09

3.35%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 111.90 40,16% (12M)

P/E

15.22

2.97%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 189.75 38,10% (12M)

P/E

28.78

1.69%

ROE

20.99%

P/BV

6.04

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 828.11 19,74% (12 M)

P/L

23.47

0.38%

ROE

-4,383.84%

P/VP

-1,028.86

CAH - Cardinal Health

$ 199.85 46,92% (12 M)

P/L

28.38

1.02%

ROE

-61.56%

P/VP

-17.47

JNJ - Johnson & Johnson

$ 227.50 52,17% (12 M)

P/L

26.05

2.29%

ROE

25.92%

P/VP

6.75

PFE - Pfizer

$ 27.00 28,40% (12 M)

P/L

19.76

6.37%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 198.71 11,21% (12 M)

P/L

83.09

3.35%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 111.90 40,16% (12 M)

P/L

15.22

2.97%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 189.75 38,10% (12 M)

P/L

28.78

1.69%

ROE

20.99%

P/VP

6.04

Frequently Asked Questions

What is the price of Innoviva (INVA) today?

The current price of Innoviva (INVA) is $ 23.57, representing a 29.22% gain over the past year. The stock began the year trading around $ 19.99 and is currently priced at $ 23.57. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not pay dividends over the past year.

Is Innoviva (INVA) a good investment?

Innoviva (INVA) is currently trading at $ 23.57 with a P/E ratio of 6.52%. This represents a 1,593% premium compared to its historical average P/E. Over the past year, the stock has gained 29.22 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 29.22%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Innoviva (INVA) stock?

You can buy Innoviva (INVA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol INVA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Innoviva (INVA) yield today?

Over the past month, Innoviva (INVA) has returned 4.02% — 29.22% over the past year, and 103.36% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Innoviva (INVA) today at the current price of $ 23.57 your total investment would be $ 2,357.00.

Based on historical performance, the investment would have grown to approximately:

$ 3,045.72 after 1 year
$ 4,793.20 after 5 years
$ 4,501.87 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INVA

Innoviva Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INVA

review the fundamentals of Innoviva shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Innoviva

Innoviva Inc.

United States

30 years

2004

5

PROFIT X PRICE INVA

Financial Results INVA

INVA cash flow

Asset, Revenue and Profit Growth - INVA

INVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions